Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis

Purpose: Chimeric Antigen Receptor T(CAR-T) cell therapy is an immunotherapy approach used in treating cancer which has seen rapid development over the decades. It becomes the preferred treatment choice after patients have failed conventional chemotherapy. Methods: We conducted a meta-analysis in 32...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ther Clin Risk Manag
Autori principali: Drokow, Emmanuel Kwateng, Ahmed, Hafiz Abdul Waqas, Amponsem-Boateng, Cecilia, Akpabla, Gloria Selorm, Song, Juanjuan, Shi, Mingyue, Sun, Kai
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6511615/
https://ncbi.nlm.nih.gov/pubmed/31190844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S203822
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi